Evaluation of urine specimen integrity in a public health STD screening program

American Journal of Clinical Pathology

Volumn 119, Issue 4, 2003, Pages 516-521

  Birch, Nathan C ^a   Stickle, Douglas F ^a   Young, Anita ^a   Medina, Philip ^b   Hinrichs, Steven H ^a,c  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b Nebraska Department of Health and Human Services   (United States)

^c NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Chlamydia trachomatis; Neisseria gonorrhoeae; Public health; Specimen integrity; Urethritis; Urine

Indexed keywords

CREATININE;

ARTICLE; CHLAMYDIA TRACHOMATIS; CREATININE URINE LEVEL; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; FORGERY; HEALTH PROGRAM; HUMAN; MASS SCREENING; NEISSERIA GONORRHOEAE; NONHUMAN; PRIORITY JOURNAL; PRISON; PUBLIC HEALTH SERVICE; RELATIVE DENSITY; SCREENING TEST; SEXUALLY TRANSMITTED DISEASE; UNITED STATES; URINALYSIS; VALIDATION PROCESS; CHLAMYDIASIS; EVALUATION; GONORRHEA; HEALTH SURVEY; ISOLATION AND PURIFICATION; LABORATORY DIAGNOSIS; METHODOLOGY; SCIENTIFIC MISCONDUCT; URINE;

CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; GONORRHEA; HUMANS; MASS SCREENING; NEBRASKA; NEISSERIA GONORRHOEAE; POPULATION SURVEILLANCE; SCIENTIFIC MISCONDUCT; SPECIFIC GRAVITY; SPECIMEN HANDLING;

EID: 85047689225     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/KQLD7JAE1B401CUN     Document Type: Article

References (24)

1. Cates W Jr. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association Panel. Sex Transm Dis. 1999;26(4 suppl):S2-S7.
2. Workowski KA, Levine WC, Wasserheit JN. US Centers for Disease Control and Prevention guidelines for the treatment of sexually transmitted diseases: an opportunity to unity clinical and public health practice. Ann Intern Med. 2002;137:255-262.
3. Holmes KK, Morse SA. Gonococcal infections. In: Fauci AS, Braunwald E, Isselbacher KJ, et al, eds. Harrison's Principles of Internal Medicine. 14th ed. New York, NY: McGraw-Hill; 1998:915-922.
4. Stamm WE. Chlamydial infections. In: Fauci AS, Braunwald E, Isselbacher KJ, et al, eds. Harrison's Principles of Internal Medicine. 14th ed. New York, NY: McGraw-Hill; 1998:1055-1064.
5. de Barbeyrac B, Rodriguez P, Dutilh B, et al. Detection of Chlamydia trachomatis by ligase chain reaction compared with polymerase chain reaction and cell culture in urogenital specimens. Genitourin Med. 1995;71:382-386.
6. Mahony JB. Multiplex polymerase chain reaction for the diagnosis of sexually transmitted diseases. Clin Lab Med. 1996;16:61-71.
7. Ridgway GL, Mumtaz G, Robinson AJ, et al. Comparison of the ligase chain reaction with cell culture for the diagnosis of Chlamydia trachomatis infection in women. J Clin Pathol. 1996;49:116-119.
8. Stamm WE. Chlamydia trachomatis: the persistent pathogen: Thomas Parran Award Lecture. Sex Transm Dis. 2001;28:684-689.
9. Marrazzo JM, White CL, Krekeler B, et al. Community-based urine screening for Chlamydia trachomatis with a ligase chain reaction assay. Ann Intern Med. 1997;127:796-803.
10. Puisis M, Levine WC, Mertz KJ. Overview of sexually transmitted diseases. In: Puisis M, ed. Clinical Practice in Correctional Medicine. St Louis, MO: Mosby; 1998.
11. Rietmeijer CA, Yamaguchi KJ, Ortiz CG, et al. Feasibility and yield of screening urine for Chlamydia trachomatis by polymerase chain reaction among high-risk male youth in field-based and other nonclinic settings: a new strategy for sexually transmitted disease control. Sex Transm Dis. 1997;24:429-435.
12. Beebe JL, Gershman KA, Kelley JK, et al. How adequate is adequate for the collection of endocervical specimens for Chlamydia trachomatis testing? Sex Transm Dis. 1999;26:579-583.
13. Gantzer ML. The value of urinalysis. Clin Lab News. January 1998:14-16.
14. Cook JD, Caplan YH, LoDico CP, et al. The characterization of human urine for specimen validity determination in workplace drug testing: a review. J Anal Toxicol. 2000;24:579-588.
15. Newman D, Price CP. Renal function and nitrogen metabolites. In: Burtis CA, Ashwood ER, eds. Clinical Practice in Correctional Medicine. 3rd ed. Philadelphia, PA: Saunders; 1999:1204-1270.
16. Rendell M, McGrane D, Cuesta M. Fatal compulsive water drinking. JAMA. 1978;240:2557-2559.
17. Fuller CE, Threattee GA, Henry JB. Basic examination of urine. In: Davey FR, Herman CJ, McPherson RA, et al, eds. Clinical Diagnosis and Management by Laboratory Methods. 20th ed. Philadelphia, PA: Saunders; 2001:367-402.
18. Needleman SB, Porvaznik M, Ander D. Creatinine analysis in single collection urine specimens. J Forensic Sci. 1992;37:1125-1133.
19. George S, Braithwaite RA. An investigation into the extent of possible dilution of specimens received for urinary drugs of abuse screening. Addiction. 1995;90:967-970.
20. Mikkelsen SL, Ash KO. Adulterants causing false negatives in illicit drug testing. Clin Chem. 1988;34:2333-2336.
21. Allon M. Renal abnormalities in sickle cell disease. Arch Intern Med. 1990;150:501-504.
22. Gulati PD, Vaishnava H. Hyposthenuric polyuric syndromes. J Assoc Physicians India. 1971;19:245-249.
23. Zambraski EJ, Rofrano TA, Ciccone CD. Effects of aspirin treatment on kidney function in exercising man. Med Sci Sports Exerc. 1982;14:419-423.
24. Edwards C, Fyfe MJ, Liu RH, et al. Evaluation of common urine specimen adulteration indicators. J Anal Toxicol. 1993;17:251-252.